TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -1 | -5 | -4 | 9 | 23 | 723 | 124 |
| P | %wins | 50 | 0 | 50 | 50 | 50 | 50 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/9/21 16:09 | 12/8/21 | KTRA | Kintara Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Praill Anthony Scott | CA | O | CFO | P | 19 | 0.6770 | 0 | 29 | 338 | 37 | D | ||||||||||||||
10/5/17 18:05 | 10/5/17 | DMPI | Delmar Pharmaceuticals, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Praill Scott | A1 | O | Chief Fi | P | 15 | 0.8520 | 0 | 18 | 59 | 47 | D | ||||||||||||||
6/28/17 11:34 | 6/26/17 | DMPI | Delmar Pharmaceuticals, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Praill Scott | A1 | O | Chief Fi | P | 15 | 3.60 | 0 | 4 | 16 | 29 | D | ||||||||||||||
6/6/17 17:23 | 6/6/17 | DMPI | Delmar Pharmaceuticals, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Praill Scott | A1 | O | CFO | P | 20 | 2.10 | 0 | 10 | 60 | 25 | D | ||||||||||||||
7/16/15 07:07 | 7/16/15 | DMPI | Delmar Pharmaceuticals, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Praill Scott | A1 | O | CFO | P.d | 30 | 0.6000 | 0 | 50 | 500 | 60 | D | -42 | -38 | -29 | -28 | -28 | -23 | -11 | -2 | 3 | -1 | -10 | 45 | 64 | 999 |
3/20/14 16:31 | 3/18/14 | DMPI | Delmar Pharmaceuticals, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Praill Scott | A1 | O | CFO | P | 13 | 1.30 | 0 | 10 | New | 10 | D | -16 | 33 | 54 | 52 | -1 | -7 | -4 | -5 | -8 | 3 | -28 | -18 | -28 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |